Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
84.82B | 79.06B | 65.50B | 55.39B | 56.00B | Gross Profit |
84.82B | 81.25B | 65.50B | 55.39B | 56.00B | EBIT |
0.00 | 57.43B | 71.75B | 32.79B | 24.08B | EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
45.77B | 39.48B | 33.36B | 25.33B | 19.85B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
147.94B | 335.58B | 309.99B | 400.72B | 373.01B | Total Assets |
3.61T | 3.44T | 3.24T | 2.92T | 2.92T | Total Debt |
0.00 | 952.37B | 838.67B | 778.50B | 824.50B | Net Debt |
-147.94B | 620.96B | 528.69B | 481.77B | 540.98B | Total Liabilities |
3.33T | 3.17T | 2.98T | 2.68T | 2.67T | Stockholders Equity |
283.11B | 269.13B | 258.87B | 243.65B | 248.28B |
Cash Flow | Free Cash Flow | |||
-159.12B | 43.00M | 32.80B | 37.10B | 80.74B | Operating Cash Flow |
-156.44B | 4.12B | 36.31B | 41.59B | 84.57B | Investing Cash Flow |
-880.00M | -1.76B | -7.65B | -4.39B | -4.72B | Financing Cash Flow |
-29.57B | 14.18B | 34.25B | -15.74B | -102.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $66.34B | 9.45 | 20.65% | 5.23% | -7.01% | 15.18% | |
76 Outperform | $59.79B | 12.46 | 8.73% | 3.95% | -2.65% | -14.84% | |
75 Outperform | $38.26B | 9.39 | 17.21% | 4.14% | 17.01% | 16.07% | |
74 Outperform | $29.76B | 12.42 | 9.39% | 2.91% | 1.20% | 1.12% | |
69 Neutral | $26.28B | 12.51 | 11.71% | 3.71% | 5.75% | 0.68% | |
64 Neutral | $12.74B | 9.83 | 7.63% | 17000.35% | 12.34% | -5.32% | |
55 Neutral | $53.99B | 12.15 | 0.10% | 5.04% | -27.31% | ― |